Avidity Biosciences brings to Novartis three RNA therapies in pivotal testing for rare neuromuscular diseases along with the technology that produced them. This platform develops drugs in a new class of targeted medicines offering potential to expand the delivery of RNA treatments beyond the liver. The post Novartis Continues RNA & Neuroscience Growth Strategy With…
At MedCity News’ Tête-à-tête Health event, executives from Sutter Health and Tampa General Hospital discussed how they are deploying AI, as well as how they are keeping governance and the human touch at the forefront. The post How Hospitals Are Keeping Up with the Rapid Rise of AI appeared first on MedCity News.
Health tech company Visana is urging the women’s health industry to expand its focus beyond reproductive care to address broader issues like cardiometabolic health, obesity and hormonal conditions that affect the majority of women outside the family-building years. The post Why the Women’s Health Space Needs to Expand Beyond Reproductive Health appeared first on MedCity…
No es fácil promover la moderación y la disciplina financiera desde las entrañas de un casino. Pero eso es lo que los empleados estatales de Massachusetts intentan hacer a diario, entre los sonidos y las luces intermitentes de las máquinas tragamonedas. En el MGM Springfield, al oeste del estado, empleados con remeras verdes se encuentran…
[Sponsored] Getting nutrients from whole foods is important, but they may get lost in the digestive system. Explore the best mobile IV therapy services in Utah to access leading treatments. The post The Ultimate Guide to the Best Mobile IV Therapy Providers in Utah appeared first on MedCity News.
The White House announcement focused on reducing the cost of some IVF drugs and clarifying options for employers to offer standalone fertility benefits for their employees and their dependents. This policy watch examines some key takeaways about the Trump IVF plan.
El cierre del gobierno federal continúa, trabado por el desacuerdo en el Congreso sobre el costo del seguro médico de 22 millones de personas que tienen planes adquiridos en los mercados establecidos por la Ley de Cuidado de Salud a Bajo Precio (ACA). Mientras tanto, un nuevo informe muestra que más de 154 millones de personas con…
Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to temperature regulation. The once-daily pill came from Bayer’s 2020 acquisition of KaNDy Therapeutics. The post Bayer Menopause Drug Lands FDA Approval, Bringing Competition to an Astellas Product appeared first on MedCity News.
Antibiotic resistance is a growing global threat with serious health and economic consequences. Yet there is progress – from rapid PCR diagnostics and AI-driven research to new drug development and innovative funding models. The post Innovations Offer Hope in the Fight Against Antibiotic Resistance appeared first on MedCity News.
Medicare Advantage enrollees were in a plan that included just under half (48%) of all physicians available to traditional Medicare beneficiaries in their area in 2022, on average. The limitations of provider networks illustrate one of the key tradeoffs for beneficiaries in choosing Medicare Advantage for their coverage.